Document is current
Any future updates will be listed below
-
Authors
Hefnawy, Amr https://orcid.org/0000-0002-5340-7571
Herpin, Matthew J.
Easton, Michael
Joshi, Shrinidh
Jordan, Don
Smyth, Hugh D. C.
Tarpy, Jonathan
- License Information
-
More Information
Article History
Accepted: 21 July 2022
First Online: 17 August 2022
Declarations
:
: Virgilant Technologies is the developer and owner of the ARI device. Smyth Lab at the University of Texas at Austin received research gifts from Virgilant Technologies including the ARI devices. H.D.C.S. consults for and has equity ownership in Respira Therapeutics, Nob Hill Therapeutics, Via Therapeutics, LLC, and CloXero Therapeutics, Inc on inhaled product development.
